Surgery for Diabetes May Be Better Than Standard Treatment (New York Times article). ... Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes (New England Journal of Medicine article).
A talk at Tuesday's“ Diabetes for the Internist” precourse reviewed some of the most significant recent advances in insulin, including new concentrations and combinations with other medications, new delivery mechanisms,
That will empower them to be engaged partners in their care.“ I don't take care of diabetes,” Dr. ... Refer to a specialist and follow up. Any patient with prediabetes, diabetes or hypertension should see an ophthalmologist.
The prospective InterAct case-cohort study conducted in 26 centers in eight European countries, is investigating how genetics and lifestyle interact to affect diabetes risk. ... Waist circumference is just as important as other risk factors for diabetes
The Closing the Gap project began by collecting data on the practices' diabetes-related procedures and patients. ... The overwhelming response led to its reprinting for phase II of the Diabetes Initiative.
Little treatments, lots of time best for back pain | Internal Medicine Meeting 2019 News | ACP Internist
catastrophizing, avoiding activities out of fear (of further injury, for example), and having depression, anxiety, obesity, comorbidities such as diabetes, headaches, or asthma, or a physically demanding job, Dr.
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease. ... It should not be
QD: News Every Day--Teens with type 2 diabetes likely to need combination therapy sooner. ... A majority of teenagers with type 2 diabetes may require combination treatment or insulin therapy within a few years of diagnosis, researchers concluded.
31, 2015. Canaglifozin (Invokana) tablets, to improve glycemic control in adults with type 2 diabetes, along with diet and exercise. ... It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment or end-stage
The FDA continues to investigate and has not determined whether the diabetes drug increases the risk of leg and foot amputations.